PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+10.96%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$6.79B
AUM Growth
+$6.79B
(+10%)
Cap. Flow
+$318M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
44.18%
Holding
154
New
27
Increased
19
Reduced
23
Closed
27
Top Buys
| 1 |
Outset Medical
OM
|
$142M |
| 2 |
CRISPR Therapeutics
CRSP
|
$112M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$110M |
| 4 |
Relay Therapeutics
RLAY
|
$99.2M |
| 5 |
Athira Pharma
ATHA
|
$57.5M |
Top Sells
| 1 |
Kodiak Sciences
KOD
|
$146M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$133M |
| 3 |
Neurocrine Biosciences
NBIX
|
$57M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$56.7M |
| 5 |
VAPO
Vapotherm, Inc. Common Stock
VAPO
|
$54.9M |
Sector Composition
| 1 | Healthcare | 82.7% |
| 2 | Industrials | 0.17% |
| 3 | Materials | 0.13% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $570M | 8.33% | 3,435,575 +664,525 | +24% | +$110M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $355M | 5.18% | 25,122,048 -60,316 | -0.2% | -$852K |
|
|
3
Iovance Biotherapeutics
IOVA
$807M
| $332M | 4.85% | 10,085,632 -1,723,862 | -15% | -$56.7M |
|
|
GBT
4
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $320M | 4.67% | 5,800,996 -41,104 | -0.7% | -$2.27M |
|
5
BridgeBio Pharma
BBIO
$9.89B
| $252M | 3.67% | 6,706,268 | – | – |
|
6
Zymeworks
ZYME
$1.12B
| $205M | 2.99% | 4,400,999 +820,000 | +23% | +$38.2M |
|
|
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $190M | 2.78% | 1,395,017 | – | – |
|
|
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
| $166M | 2.42% | 3,481,148 -33,210 | -0.9% | -$1.58M |
|
|
ATNX
9
DELISTED
Athenex, Inc. Common Stock
ATNX
| $161M | 2.36% | 13,532,467 +2,000,000 | +17% | +$23.8M |
|
|
VBIV
10
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $157M | 2.3% | 55,042,465 | – | – |
|
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $149M | 2.17% | 1,548,715 -592,695 | -28% | -$57M |
|
|
12
Outset Medical
OM
$247M
| $142M | 2.08% | +2,847,822 | New | +$142M |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $115M | 1.68% | 826,164 -73,808 | -8% | -$10.3M |
|
|
14
CRISPR Therapeutics
CRSP
$4.71B
| $112M | 1.64% | +1,341,308 | New | +$112M |
|
|
15
Relay Therapeutics
RLAY
$619M
| $99.2M | 1.45% | +2,329,407 | New | +$99.2M |
|
16
MeiraGTx Holdings
MGTX
$587M
| $85.2M | 1.24% | 6,433,277 | – | – |
|
|
QTNT
17
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $83.3M | 1.22% | 16,200,818 +2,911,764 | +22% | +$15M |
|
|
ALBO
18
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $78.8M | 1.15% | 2,360,139 +400,000 | +20% | +$13.3M |
|
|
IMMU
19
DELISTED
Immunomedics Inc
IMMU
| $77.6M | 1.13% | 912,140 +550,000 | +152% | +$46.8M |
|
20
Novavax
NVAX
$1.21B
| $76.7M | 1.12% | 707,715 +357,715 | +102% | +$38.8M |
|
21
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $66.7M | 0.97% | 3,636,485 +3,091,200 | +567% | +$56.7M |
|
22
Korro Bio
KRRO
$217M
| $62.6M | 0.91% | 3,256,518 +222,222 | +7% | +$4.27M |
|
|
FMTX
23
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $62.3M | 0.91% | 1,250,000 | – | – |
|
|
24
Kodiak Sciences
KOD
$478M
| $61.8M | 0.9% | 1,043,021 -2,470,551 | -70% | -$146M |
|
|
BPMC
25
DELISTED
Blueprint Medicines
BPMC
| $61.6M | 0.9% | 664,574 -24,050 | -3% | -$2.23M |
|